$80,000 of CLEANSPARK INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Banking reform as it relates to digital assets Financial inclusion as it relates to digital assets Tax reform tariff issues related to imported goods Issues related to importing goods"
You can find more data on corporate lobbying on Quiver Quantitative.
CLSK Insider Trading Activity
CLSK insiders have traded $CLSK stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CLSK stock by insiders over the last 6 months:
- ROGER PAUL BEYNON sold 50,000 shares for an estimated $525,285
- THOMAS LEIGH WOOD sold 44,444 shares for an estimated $357,329
- ZACHARY BRADFORD (CEO and President) sold 10,533 shares for an estimated $112,064
- AMANDA CAVALERI has made 0 purchases and 2 sales selling 13,000 shares for an estimated $103,600.
- S. MATTHEW SCHULTZ (Executive Chairman) sold 9,010 shares for an estimated $95,860
- SCOTT EUGENE GARRISON (Chief Operating Officer) sold 1,337 shares for an estimated $14,224
- GARY ANTHONY VECCHIARELLI (Chief Financial Officer) sold 717 shares for an estimated $7,628
- TAYLOR MONNIG (Chief Technology Officer) sold 239 shares for an estimated $2,542
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CLSK Hedge Fund Activity
We have seen 170 institutional investors add shares of CLSK stock to their portfolio, and 153 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC added 4,911,600 shares (+452.5%) to their portfolio in Q1 2025, for an estimated $33,005,952
- JANE STREET GROUP, LLC removed 4,495,966 shares (-98.9%) from their portfolio in Q1 2025, for an estimated $30,212,891
- STATE STREET CORP added 4,342,621 shares (+64.0%) to their portfolio in Q1 2025, for an estimated $29,182,413
- ASSENAGON ASSET MANAGEMENT S.A. removed 4,336,612 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $29,142,032
- MORGAN STANLEY removed 2,927,256 shares (-23.4%) from their portfolio in Q1 2025, for an estimated $19,671,160
- BANK OF AMERICA CORP /DE/ removed 2,776,210 shares (-80.8%) from their portfolio in Q1 2025, for an estimated $18,656,131
- DIMENSIONAL FUND ADVISORS LP added 2,560,425 shares (+1376.3%) to their portfolio in Q2 2025, for an estimated $28,241,487
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CLSK Analyst Ratings
Wall Street analysts have issued reports on $CLSK in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Chardan Capital issued a "Buy" rating on 08/12/2025
- B. Riley Securities issued a "Buy" rating on 08/08/2025
- Cantor Fitzgerald issued a "Overweight" rating on 08/08/2025
- Macquarie issued a "Outperform" rating on 08/08/2025
- Ladenburg Thalmann issued a "Buy" rating on 07/28/2025
- JP Morgan issued a "Overweight" rating on 07/28/2025
To track analyst ratings and price targets for CLSK, check out Quiver Quantitative's $CLSK forecast page.
CLSK Price Targets
Multiple analysts have issued price targets for $CLSK recently. We have seen 6 analysts offer price targets for $CLSK in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- James McIlree from Chardan Capital set a target price of $20.0 on 08/12/2025
- Nick Giles from B. Riley Securities set a target price of $17.0 on 08/08/2025
- Paul Golding from Macquarie set a target price of $20.0 on 08/08/2025
- Brett Knoblauch from Cantor Fitzgerald set a target price of $26.0 on 08/08/2025
- Reginald Smith from JP Morgan set a target price of $15.0 on 07/28/2025
- Jon Hickman from Ladenburg Thalmann set a target price of $20.25 on 07/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
